Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,271 INR | -0.77% | -3.05% | -6.28% |
05-06 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
04-16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.28% | 1.16B | |
+20.29% | 43.27B | |
+25.20% | 22.92B | |
+20.29% | 15.43B | |
+12.48% | 12.95B | |
+42.43% | 11.83B | |
-8.53% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution